Determining Orphan Drug Eligibility for Reduced Pricing
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Sep 29, 2014
filing date -
Sep 29, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Systems, methods, and computer-readable media are disclosed for determining whether an orphan drug is eligible for replenishment at a 340B price for the drug by evaluating orphan drug identification data, patient encounter data, and/or dispensing data with respect to one or more eligibility criteria to determine whether the orphan drug has been prescribed, dispensed, or otherwise used to treat the rare disease or condition for which it is designated or an alternate condition.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully